Shares in Haemonetics (NYSE:HAE) have stayed steady today, down only slightly after the medical device maker beat expectations on Wall Street with its 4th quarter and full 2017 fiscal year earnings results. The Braintree, Mass.-based company posted losses of $51.1 million, or 98¢ per share, on sales of $228.1 million for the 3 months ended April […]
Haemonetics
Haemonetics posts Q3 beat, lifts guidance
Haemonetics (NYSE:HAE) today released its 3rd quarter earnings, topping expectations from analysts on The Street and raising its outlook for the rest of its fiscal year 2017. The Braintree, Mass.-based company posted profits of $15.4 million, or 30¢ per share, on sales of $227.8 million for the 3 months ended Dec. 31, for a significant swing […]
Haemonetics tops Q2 earnings forecast by 11c
Haemonetics (NYSE:HAE) yesterday posted fiscal 2nd-quarter numbers that topped expectations on Wall Street by more than a dime, despite flat sales growth, as the company executes a reorganization plan. The Braintree, Mass.-based blood management company posted profits of $19.8 million, or 38¢ per share, on sales of $220.3 million for the 3 months ended Oct. 1, […]
Analogic CEO Green steps away | Personnel Moves Nov 4, 2016
Analogic (NSDQ:ALOG) said late last month its prez and CEO James Green has stepped away from his position to pursue other opportunities. Company director and former Enovate Medical exec chair and CEO Dr. Fred Parks has been named to take over Green’s position. “Jim Green led Analogic during a period of meaningful development and growth, and […]
Haemonetics taps ex-Medtronic CIO Burke as new CFO | Personnel Moves August 4, 2016
Haemonetics taps ex-Medtronic CIO Burke as new CFO Haemonetics (NYSE:HAE) said this week it tapped former Medtronic (NYSE:MDT) chief integration officer William Burke as its new chief financial officer, effective August 8. Burker operated as CIO with Medtronic since 2015, serving during the integration of Covidien. Prior to that, he held various finance positions with […]
Haemonetics sees shares rise on Q1 release
Haemonetics (NYSE:HAE) has seen shares rise despite releasing 1st quarter earnings that saw losses grow and earnings per share shrink compared to last year. The Braintree, Mass.-based company reported losses of $10.3 million, or 20¢ per share, on sales of $210 million for the 3 months ended July 2. The company saw bottom-line losses grow from […]
NuVasive co-founder McKinley is Vascular Dynamics new COO | Personnel Moves June 9, 2016
NuVasive co-founder McKinley is Vascular Dynamics new COO Vascular Dynamics said it tapped NuVasive Inc. (NSDQ:NUVA) co-founder and former CEO James McKinley as its new chief operating officer. McKinley has held leadership positions at Advent Medical, Endosphere, Farallon Medical and Nellix, as well as NuVasive. “It is a tremendous opportunity to add Jim to our management team. […]
Layoffs ahead as Haemonetics restructures, names new CEO
Haemonetics (NYSE:HAE) said yesterday that it plans to take a pre-tax charge of $26 million, including $17 million worth of “termination benefits,” as part of another round of layoffs aimed at boosting profitability and growth. The Braintree, Mass.-based blood management company also said it named Chris Simon to be its new CEO, replacing interim chief Ron […]
Autonomic Technologies taps ex-Thoratec’s Pellegrini for CEO | Personnel Moves April 15, 2016
Icahn claims success, steps back from Hologic | Personnel Moves
Billionaire investor Carl Icahn said last Friday that he will begin to ramp down his involvement with Hologic (NSDQ:HOLX), claiming his intervention with the company to be a success. As part of the stepping away process, Icahn representatives Jonathan Christodoro and Samuel Merksamer stepped down from the board and will not be replaced, according to SEC […]
HeartWare taps ex-Medtronic exec Oesterle for board | Personnel Moves
HeartWare International (NSDQ:HTWR) is looking to get in on Dr. Stephen Oesterle, an Ex-Medtronic (NYSE:MDT) exec who moved to the venture capital firm New Enterprise Associates last Sept., saying this week that it expanded its board to accommodate Oesterle. Oesterle will officially come aboard on Jan. 18, and his appointment included an expansion to HeartWare’s board […]